Identification of High-Risk Brugada Syndrome Patients by Combined Analysis of Late Potential and T-Wave Amplitude Variability on Ambulatory Electrocardiograms

DOI Web Site PubMed 被引用文献13件 参考文献34件
  • Yoshioka Koichiro
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Amino Mari
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Zareba Wojciech
    Heart Research Follow-up Program, Cardiology, University of Rochester Medical Center
  • Shima Makiyoshi
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Matsuzaki Atsushi
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Fujii Toshiharu
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Kanda Shigetaka
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Deguchi Yoshiaki
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Kobayashi Yoshinori
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Ikari Yuji
    Department of Cardiovascular Medicine, Tokai University School of Medicine
  • Kodama Itsuo
    Nagoya University
  • Tanabe Teruhisa
    Department of Cardiovascular Medicine, Tokai University School of Medicine

この論文をさがす

抄録

Background: Risk stratification is important in the management of Brugada syndrome (BrS). Late potentials (LPs) and T-wave amplitude variability (TAV) in high-resolution ambulatory electrocardiography (ECG) were retrospectively investigated. Methods and Results: One hundred and twenty-seven patients diagnosed with BrS on 12-lead ECG were classified into 3 groups: documented ventricular fibrillation (VF)/asystole (n=19), episodes of syncope alone (n=30), and asymptomatic (n=78). Healthy volunteers were enrolled as controls (n=25). In the BrS patients, LPs showed appreciable circadian periodicity; filtered QRS duration (fQRS) and duration of the terminal low-amplitude signal <40μV (LAS40) increased, whereas root mean square voltage of the terminal 40ms of the fQRS (RMS40) decreased at night compared with the day. TAV did not have such a circadian periodicity. LP-positive incidence (night-time) and peak TAV were as follows: VF/asystole>syncope/asymptomatic>control (P<0.001). VF/asystole was discriminated from control at a ratio of 81–84% by night-time LPs (fQRS >116ms, LAS40 >35ms, RMS40 <25μV) or peak TAV (>54μV); VF/asystole was discriminated from syncope/asymptomatic at a ratio of 60–69%, by night-time LPs (fQRS >122ms, LAS40 >42ms, RMS40 <18μV) or peak TAV (>58μV). Combined analysis of LPs and peak TAV increased the discriminant ratio up to 93% and 77%, respectively. Conclusions: Analysis of both LPs and TAV (taking circadian periodicity into account) is useful in identification of high-risk BrS patients.  (Circ J 2013; 77: 610–618)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 77 (3), 610-618, 2013

    一般社団法人 日本循環器学会

被引用文献 (13)*注記

もっと見る

参考文献 (34)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ